Akcea Therapeutics, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-07-19: Reporting owner IONIS PHARMACEUTICALS INC; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2017-07-13: Reporting owner IONIS PHARMACEUTICALS INC; Form 3; Security Series A Preferred Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-07-19 | IONIS PHARMACEUTICALS INC 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −28,884,540 0 owned after | $0.00 | 2017-07-21 | |
| 2017-07-13 holding as of filing | IONIS PHARMACEUTICALS INC 10% Owner | 3 | Series A Preferred Stock Derivative · Direct | Holding | no price filed | 2017-07-13 |